Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × Advanced Fallopian Tube Carcinoma × Diphtheria Toxoid × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1 Gynecologic 1

Conditions

Leukemia, Lymphocytic, Chronic, B-Cell 1 Glioma 1 Glioblastoma 1 Advanced Fallopian Tube Carcinoma 1

Interventions

adacel 1 Tetanus Toxoid 1 Specimen Handling 1 Magnetic Resonance Spectroscopy 1 Leukapheresis 1 Diphtheria-Tetanus-acellular Pertussis Vaccines 1 Diphtheria-Tetanus Vaccine 1 Diphtheria Toxoid 1 Biopsy 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06639074 2025-10-02

Folate Receptor Alpha Dendritic Cells (FRαDCs) or Placebo for the Treatment of Patients With Stage III or IV Ovarian, Fallopian Tube, or Primary Peritoneal Cancer, FAROUT Trial

Mayo Clinic

Phase 2 Recruiting

GynecologicSarcoma

Advanced Fallopian Tube Carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡